Effects of Arg16Gly polymorphism in ADRB2 gene on responses to salmeterol or montelukast added to inhaled corticosteroids in Japanese asthmatic subjects

S. Konno, H. Makita, N. Hizawa, K. Shimizu, F. Kokubu, T. Saito, T. Endo, H. Ninomiya, H. Iijima, N. Kaneko, M. Nishimura (Sapporo, Tsukuba, Yokohama, Toukai, Higashiibaragi, Noda, Kamogawa, Japan)

Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Session: Asthma treatment: efficacy and safety
Session type: Thematic Poster Session
Number: 2089
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Konno, H. Makita, N. Hizawa, K. Shimizu, F. Kokubu, T. Saito, T. Endo, H. Ninomiya, H. Iijima, N. Kaneko, M. Nishimura (Sapporo, Tsukuba, Yokohama, Toukai, Higashiibaragi, Noda, Kamogawa, Japan). Effects of Arg16Gly polymorphism in ADRB2 gene on responses to salmeterol or montelukast added to inhaled corticosteroids in Japanese asthmatic subjects. Eur Respir J 2012; 40: Suppl. 56, 2089

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Arg16Gly polymorphism of the β2-adrenergic receptor gene does not modulate clinical response to salmeterol in subjects with asthma
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008

Characterization of asthma exacerbations by Arg16Gly genotype in subjects with asthma receiving salmeterol alone or with fluticasone propionate
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

Lack of effect of promoter, coding and 3‘ polymorphisms of the β2-adrenergic receptor (ADRB2) on the clinical response to salmeterol alone or with fluticasone propionate in subjects with asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

The influence of β2 adrenoceptor polymorphisms on the response to formoterol, montelukast or higher dose budesonide in patients with uncontrolled asthma despite low dose budesonide
Source: Annual Congress 2004 - Further pharmacological and clinical evidence for using long-acting β-agonists with inhaled corticosteroids
Year: 2004


Comparison of add-on of leukotriene receptor antagonist vs. long-acting beta2-agonist on FeNO in asthmatic children on regular inhaled budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 431s
Year: 2002

Salmeterol response is not affected by beta2-adrenergic receptor genotype in patients with persistent asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 505s
Year: 2005

Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Assessment of asthma control in asthmatic patients Brazilian carriers of the Arg16Gly polymorphism of the β2 adrenorreceptor gene
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009


ADRB2 Gly16Arg polymorphism, asthma control and lung function decline
Source: Eur Respir J 2011; 38: 1029-1035
Year: 2011



The gln27 beta adrenoceptor polymorphism is associated with bronchodilator reversibility in subjects with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 96s
Year: 2002

The linkage of bronchial hyperreactivity with Arg16Gly and Gln27Glu polymorphisms of ß2-adrenoreceptors of patients with atopic bronchial asthma in Kyrgyz nation
Source: Eur Respir J 2006; 28: Suppl. 50, 650s
Year: 2006

Influence of ADRB2 gene polymorphism on cold airway hyperresponsiveness and asthma control depending on inhaled glucocorticoids use
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012


ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium
Source: International Congress 2019 – Genes and environment
Year: 2019

Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 40s
Year: 2001

Differences in bronchoprotective subsensitivity between formoterol (FM) and salmeterol (SM) are associated with β2-adrenoceptor polymorphism
Source: Eur Respir J 2002; 20: Suppl. 38, 306s
Year: 2002

Effect of long-acting ß-agonist on bronchodilator response in children with asthma
Source: Eur Respir J, 56 (3) 1902010; 10.1183/13993003.02010-2019
Year: 2020



Association of β2-adrenoceptor genotypes with bronchodilatory effect of tiotropium in COPD
Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD
Year: 2008



Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010


Additional anti-inflammatory effects of inhaled budesonide/formoterol over inhaled budesonide in subjects with atopic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

The linkage of Arg16Gly polymorphism of β2 adrenoreceptor with expression of reversibility of bronchial obstruction of patients with atopic bronchial asthma in Kyrgyz nation
Source: Eur Respir J 2006; 28: Suppl. 50, 236s
Year: 2006